No trip needed for psychedelics to lift mood?
Science (New York, N.Y.) June 9, 2023 Cathleen O'Grady 2 citations
LSD and psilocin, the active compounds in magic mushrooms, bind to the same molecular targets in the brain that are affected by antidepressant medications. This finding suggests a shared mechanism between psychedelics and conventional antidepressants at the receptor level, potentially explaining why psychedelics may have therapeutic effects on mood disorders.